首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: An ISPOR-AMCP-NPC good practice task force report
【24h】

Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: An ISPOR-AMCP-NPC good practice task force report

机译:评估用于指导卫生保健决策的建模研究的相关性和可信度的问卷调查:ISPOR-AMCP-NPC良好实践工作组报告

获取原文
获取原文并翻译 | 示例
           

摘要

The evaluation of the cost and health implications of agreeing to cover a new health technology is best accomplished using a model that mathematically combines inputs from various sources, together with assumptions about how these fit together and what might happen in reality. This need to make assumptions, the complexity of the resulting framework, the technical knowledge required, as well as funding by interested parties have led many decision makers to distrust the results of models. To assist stakeholders reviewing a model's report, questions pertaining to the credibility of a model were developed. Because credibility is insufficient, questions regarding relevance of the model results were also created. The questions are formulated such that they are readily answered and they are supplemented by helper questions that provide additional detail. Some responses indicate strongly that a model should not be used for decision making: these trigger a "fatal flaw" indicator. It is hoped that the use of this questionnaire, along with the three others in the series, will help disseminate what to look for in comparative effectiveness evidence, improve practices by researchers supplying these data, and ultimately facilitate their use by health care decision makers.
机译:同意涵盖一项新的卫生技术的成本和健康影响的评估,最好是使用一种模型来完成,该模型在数学上将来自各种来源的输入以及有关这些输入如何组合以及实际情况可能发生的假设进行组合。这就需要做一些假设,结果框架的复杂性,所需的技术知识以及有关方面的资助,导致许多决策者不信任模型的结果。为了帮助利益相关者审查模型的报告,提出了与模型的信誉有关的问题。由于可信度不足,因此也产生了有关模型结果相关性的问题。制定问题的方式使其易于回答,并辅以提供更多详细信息的辅助问题。一些回应强烈表明,不应将模型用于决策:这会触发“致命缺陷”指标。希望该调查表以及本系列中的其他三个调查表的使用将有助于传播在比较有效性证据中寻找的内容,改善提供这些数据的研究人员的实践,并最终促进医疗保健决策者的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号